Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients

BACKGROUND: Intravitreal methotrexate has been proven to be an effective treatment method for vitreoretinal lymphoma. However, keratopathy occurs as the major side effect during treatment in most cases. The purpose of this study is to describe the characteristics of primary central nervous system ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xian, Zhou, Xianjin, Shi, Huimin, Lai, Jie, Wang, Qingping, Li, Yi, Chen, Kun, Li, Qingjian, Zhou, Qiang, Cao, Xia, Chen, Bobin, Xiao, Jianjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216350/
https://www.ncbi.nlm.nih.gov/pubmed/32397978
http://dx.doi.org/10.1186/s12886-020-01464-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216350/
https://www.ncbi.nlm.nih.gov/pubmed/32397978
http://dx.doi.org/10.1186/s12886-020-01464-3

Ejemplares similares